Dichloromethane → HCID 67458952, compound
Reaction equation
CS(OCC#[C:8][C:9]1[CH:14]=[C:13]([CH3:15])[CH:12]=[CH:11][C:10]=1[NH:16][C:17]([CH:19]1[O:24][C:23]2[CH:25]=[CH:26][C:27]([O:29][C:30]([F:33])([F:32])[F:31])=[CH:28][C:22]=2[NH:21][CH2:20]1)=[O:18])(=O)=O.[CH3:34][CH2:35][N:36]([CH:40]([CH3:42])C)[CH:37](C)[CH3:38].N1CC[O:46]CC1.[Cl:49]CCl>>[ClH:49].[ClH:49].[CH3:15][C:13]1[CH:12]=[CH:11][C:10]([NH:16][C:17]([CH:19]2[O:24][C:23]3[CH:25]=[CH:26][C:27]([O:29][C:30]([F:32])([F:33])[F:31])=[CH:28][C:22]=3[NH:21][CH2:20]2)=[O:18])=[C:9]([C:8]#[C:34][CH2:35][N:36]2[CH2:40][CH2:42][O:46][CH2:38][CH2:37]2)[CH:14]=1Participants
5
Procedure
To 3-(5-methyl-2-(6-(trifluoromethoxy)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamido)phenyl)prop-2-ynyl methanesulfonate (20 mg, 0.04 mmol) in dichloromethane (1 mL) and DIEA (0.1 mmol) was added morpholine (36 μL, 0.4 mmol). The mixture was stirred for 10 hrs at room temperature. The mixture was concentrated in vacuo and then taken up in methanol. Purification via HPLC (10-99% CH3CN/5 mM HCl) provided N-(4-methyl-2-(3-morpholinoprop-1-ynyl)phenyl)-6-(trifluoromethoxy)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide bis-hydrochloride (5 mg, 22% yield). LC/MS m/z 476.5 [M+H]+.
Workup
- concentrationThe mixture was concentrated in vacuo
- customPurification via HPLC (10-99% CH3CN/5 mM HCl)
Sources & evidence
- ORD record
- ord-d69a3a97dcf74a1986e44e4935a25454
- Source dataset
- uspto-grants-2015_04
- Patent number
- US08999976B2
Reaction notes
Loading…